Previous close | 256.68 |
Open | 255.79 |
Bid | 256.47 x 1300 |
Ask | 256.99 x 900 |
Day's range | 253.90 - 256.91 |
52-week range | 202.13 - 256.91 |
Volume | |
Avg. volume | 5,941,136 |
Market cap | 526.579B |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | 30.97 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.08 (0.81%) |
Ex-dividend date | 08 Nov 2023 |
1y target est | N/A |
Over long periods, dividend stocks tend to outperform their non-dividend-paying counterparts. There are likely several reasons for this, one of which is that sustaining a dividend program requires a solid underlying business. It's a Dividend King with 52 consecutive years of payout hikes -- if you include the time it spent as a unit of Abbott Laboratories.
These stocks have incredible long-term potential and are also benefiting from the current market rally.
Key Insights Significantly high institutional ownership implies Visa's stock price is sensitive to their trading...